C

Centessa Pharmaceuticals plc
D

CNTA

17.030
USD
-1.14
(-6.27%)
Market Closed
Volume
13,743
EPS
-2
Div Yield
-
P/E
-11
Market Cap
2,245,328,456
OverviewSignalsIdeasNews
Related Instruments
    C
    CTRM
    -0.15000
    (-4.07%)
    3.54000 USD
    D
    DNMR
    -0.16000
    (-1.82%)
    8.64000 USD
    G
    GNT
    0.05000
    (0.90%)
    5.61000 USD
    META
    META
    -22.99
    (-3.98%)
    558.93 USD
    More
News

Title: Centessa Pharmaceuticals plc

Sector: Healthcare
Industry: Biotechnology
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.